Neonaucleoside C



Compound IDCDAMM02234
Common nameNeonaucleoside C
IUPAC name1-[[3-ethenyl-5-methoxycarbonyl-2-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydro-2H-pyran-4-yl]methyl]-4-[5-ethenyl-1-oxo-6-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,4a,5,6-tetrahydro-3H-pyrano[3,4-c]pyran-3-yl]-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic acid
Molecular formulaC44H54N2O20

Experimental data

Retention time0.45
Adduct[M+H]+
Actual mz931.334
Theoretical mz931.334
Error0.08
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score6.0515

Identifiers and class information

Inchi keyAPXDLYAWLHQGTH-RUDXOEORNA-N
SmilesO=C(O)C1NC(C=2NC=3C=CC=CC3C2C1C4OC(=O)C5=COC(OC6OC(CO)C(O)C(O)C6O)C(C=C)C5C4)CC7C(=COC(OC8OC(CO)C(O)C(O)C8O)C7C=C)C(=O)OC
SuperclassLipids and lipid-like molecules
ClassPrenol lipids

Pharmacokinetic properties

Number of descriptor values(#stars)16
Number of non-conjugated amine groups (#amine)1
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)1
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)20
Number of reactive functional groups (#rtvFG)6
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)930.912
Computed dipole moment(dipole)16.673
Total solvent accessible surface area (SASA)994.592
Hydrophobic component of SASA (FOSA)367.634
Hydrophilic component of SASA (FISA)366.525
Pie component of the SASA (PISA)260.433
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)2253.09
Number of hydrogen bond donors (donorHB)11
Number of hydrogen bond acceptors (accptHB)32.3
Free energy of solvation of dipole (dip^2/V)0.123387
Index of cohesive interaction in solids (ACxDN^.5/SA)0.107709
Globularity descriptor (glob)0.835677
Predicted polarizability in cubic angstroms (QPpolrz)73.66
Predicted hexadecane/gas partition coefficient (QPlogPC16)24.948
Predicted octanol/gas partition coefficient (QPlogPoct)61.395
Predicted water/gas partition coefficient (QPlogPw)49.891
Predicted octanol/water partition coefficient (QPlogPo/w)-4.374
Predicted aqueous solubility (QPlogS)-0.691
Conformation-independent predicted aqueous solubility (CIQPlogS)-4.467
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-4.352
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)0.209
Predicted brain/blood partition coefficient (QPlogBB)-3.742
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)0.073
Predicted skin permeability, log Kp (QPlogKp)-7.5
PM3 calculated ionization potential (IP(ev))8.406
PM3 calculated electron affinity (EA(eV))0.708
Number of likely metabolic reactions (#metab)15
Prediction of binding to human serum albumin (QPlogKhsa)-1.852
Predicted qualitative human oral absorption (HumanOralAbsorption)1
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)0
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)343.601
Number of nitrogen and oxygen atoms (#NandO)22
Number of violations of Lipinski’s rule of five (RuleOfFive)3
Number of violations of Jorgensen’s rule of three (RuleOfThree)2

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P15692VEGFAVascular endothelial growth factor AT20761SEA
P05230FGF1Acidic fibroblast growth factorT18639SEA
P09038FGF2Basic fibroblast growth factorT31621SEA
P60568IL2Interleukin-2T61698SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T20761DI0095Colorectal cancer[ICD-11: 2B91]P15692VEGFA
T20761DI0365Retinopathy[ICD-11: 9B71]P15692VEGFA
T20761DI0430Vascular system developmental anomaly[ICD-11: LA90]P15692VEGFA
T18639DI0081Chronic arterial occlusive disease[ICD-11: BD4Z]P05230FGF1
T18639DI0102Coronary atherosclerosis[ICD-11: BA52]P05230FGF1
T31621DI0005Acne vulgaris[ICD-11: ED80]P09038FGF2
T61698DI0275Multiple sclerosis[ICD-11: 8A40]P60568IL2
T61698DI0361Renal cell carcinoma[ICD-11: 2C90]P60568IL2

Copyright © 2025